HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Inc.

Stocks ended the week higher as investors looked past policy noise and leaned back into risk assets. The Dow Jones Industrial Average (DJIA) rose 0...

The Week That Was, The Week Ahead: Macro and Markets, June 14

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genmab (GMAB), HCA Healthcare (HCA) and Thermo Fishe...

Wall Street Analysts Are Bullish on Top Healthcare Picks

In a report released on June 8, Andrew Mok CFA from Barclays maintained a Buy rating on HCA Healthcare, with a price target of $496.00. The company...

Barclays Sticks to Its Buy Rating for HCA Healthcare (HCA)

In a report released today, Lance Wilkes from Bernstein maintained a Hold rating on HCA Healthcare, with a price target of $413.00. Wilkes covers t...

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Health Catalyst (HCAT) and Medicus Pharma Ltd (MDCX)...

Analysts Are Bullish on Top Healthcare Stocks: Health Catalyst (HCAT), Medicus Pharma Ltd (MDCX)

Health Catalyst ( ($HCAT) ) just unveiled an update. On June 4, 2026, Health Catalyst agreed to sell all equity interests in Vitalware, its mid-rev...

Health Catalyst Divests Vitalware to Strengthen Core Focus

Hall Chadwick Acquisition Corp. Class A ( ($HCAC) ) has issued an announcement. On June 1, 2026, Hall Chadwick Acquisition Corp. announced it had s...

Hall Chadwick SPAC to Merge with REEcycle Holdings

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVS Health (CVS), Dexcom (DXCM) and HCA Healthcare (...

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Dexcom (DXCM) and HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Humana (HUM) and HCA Healthcare (HCA). Humana (HUM) In a report r...

Analysts Conflicted on These Healthcare Names: Humana (HUM) and HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCA) and Zai Lab (ZLAB). HCA Healthcare (HCA) J.P...

Current Quarter	$7.37	Next Quarter	$7.26
Current Year	$30.07	Next Year	$32.98
QoQ Growth	-1.5%	YoY Growth	+9.7%
3Y EPS CAGR	+13.9%	Target Price	$500.43
Consensus	Buy	Upside	+33.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HCA	$375.17	-3.35%	2.66M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HCA	$375.17	-3.3%	2.66M
3
4
5
6

HCA

HCA

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get HCA Healthcare Inc. Data in Excel

Get HCA Healthcare Inc. Data in Excel